ENT treatment led to increased expression of ciita, tap1, tap2, cd74, and major histocompatibility genes—involved in antigen processing and presentation—suggesting an increased ability to T cells to engage tumor cells, consistent with previous reports.16 The gene discussed is TAP2; the disease is neoplasm.